[MO12] Mini-Oral Session 12　血液2（リンパ系腫瘍）
【E】

[MO12-3] Subcutaneous Epcoritamab in Relapsed/Refractory Chronic Lymphocytic Leukemia: Preliminary Results From EPCORE CLL-1

^○Anthony Mato¹, Jacob Haaber Christensen², Hans Herluf Bentzen³, Carsten Utoft Niemann⁴, Martin Hutchings⁴, Jenny Chen⁵, Daniela Hoehn⁵, Marcia Rios⁵, Tammy Palenski⁶, Tommy Li⁵, Arnon P. Kater⁷ (1.Memorial Sloan Kettering Cancer Center, Chronic Lymphocytic Leukemia Program, New York, NY, USA, 2.Odense University Hospital, Odense, Denmark;, 3.Aarhus University Hospital, Aarhus, Denmark, 4.Rigshospitalet, Copenhagen, Denmark, 5.Genmab, Princeton, NJ, USA, 6.AbbVie, North Chicago, IL, USA, 7.Amsterdam UMC, Cancer Center Amsterdam, University of Amsterdam, Netherlands)